We are also developing lipid nanoparticles (LNP) containing RNA for gene therapy These LNP-RNA complexes treat chronic autoimmune, metabolic and genetic diseases. LNP complexes are well known for immunization. However, our LNPs are different from those used for vaccines.
Vaccine-related LNPs are designed to disintegrate for short term use in the body and produce an immune reaction. However, HighField’s LNPs are tailored for stability, sustained circulation, minimum immune reaction and long term efficacy. This results in longer lasting production of greater amounts of the therapeutic proteins.
Highfield 的优势
Our immuno-oncology and LNP platforms are built upon our unique capability to optimize components of a lipid system directed to specific disease tissue. Combined with our proprietary system that consistently produces very high quality lipid structures , HighField can produce therapeutics with maximum efficacy and safety.
Treating chronic and genetic diseases with LNP gene therapies
We are creating LNP-RNA complexes that produce therapeutic proteins in the body. These proteins treat chronic diseases such as autoimmune, genetic and metabolic disorders. Our LNP-RNA complexes create a steady long-term production of the therapeutic protein with little or no immune response.